| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16876299P | 1999-12-06 | 1999-12-06 | |
| US60168762 | 1999-12-06 | ||
| US70366700A | 2000-11-02 | 2000-11-02 | |
| US09703667 | 2000-11-02 | ||
| PCT/CA2000/001311WO2001041732A1 (en) | 1999-12-06 | 2000-11-03 | Compositions and methods for intranasal delivery of active agents to the brain |
| Publication Number | Publication Date |
|---|---|
| AU1261501Atrue AU1261501A (en) | 2001-06-18 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU12615/01AAbandonedAU1261501A (en) | 1999-12-06 | 2000-11-03 | Compositions and methods for intranasal delivery of active agents to the brain |
| Country | Link |
|---|---|
| AU (1) | AU1261501A (en) |
| CA (1) | CA2325106A1 (en) |
| WO (1) | WO2001041732A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| JP2005503425A (en) | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | Delivery of drug ester by the prescribed inhalation route |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| EP1446102A1 (en) | 2001-11-21 | 2004-08-18 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
| JP2007516149A (en) | 2003-05-21 | 2007-06-21 | アレックザ ファーマシューティカルズ， インコーポレイテッド | Method for controlling uniformity of substrate temperature, built-in heating unit and chemical supply unit using the same |
| US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
| ATE319426T1 (en) | 2003-11-11 | 2006-03-15 | Mattern Udo | NASAL FORMULATION WITH CONTROLLED RELEASE OF SEXUAL HORMONES |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| WO2006022714A1 (en) | 2004-08-12 | 2006-03-02 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| US20060252738A1 (en)* | 2005-05-06 | 2006-11-09 | Phero Tech Inc. | Method for preparing and using water-based steroid pheromone compositions |
| JP2009506076A (en) | 2005-08-26 | 2009-02-12 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ | Therapeutic procedures for drug delivery for trigeminal neuralgia |
| RU2480208C2 (en) | 2006-10-04 | 2013-04-27 | М Унд П Патент Акциенгезелльшафт | Delivery system with controlled release for nasal application of neurotransmitters |
| WO2008112661A2 (en) | 2007-03-09 | 2008-09-18 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
| US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| CN102652815B (en)* | 2012-05-09 | 2013-11-06 | 武汉市健恒生物科技有限责任公司 | Medicament composite for improving memory as well as preparation method and application thereof |
| US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
| RS65034B1 (en) | 2015-01-07 | 2024-02-29 | Tonix Pharma Ltd | Magnesium-containing oxytocin formulations and methods of use |
| US10517879B2 (en)* | 2015-12-17 | 2019-12-31 | Performance Labs PTE. LTD. | Device and method of using volatile organic compounds that affect mood, emotion or a physiologic state |
| RS66592B1 (en) | 2016-04-12 | 2025-04-30 | Tonix Pharma Ltd | OXYTOCIN FORMULATIONS CONTAINING MAGNESIUM AND PROCEDURES FOR THEIR ADMINISTRATION |
| EP3746138A4 (en) | 2018-02-02 | 2021-11-03 | Alexza Pharmaceuticals, Inc. | ELECTRIC CONDENSATION AEROSOL DEVICE |
| US11813354B1 (en)* | 2019-01-11 | 2023-11-14 | Shear Kershman Laboratories, Inc | Trans-mucosal delivery system for testosterone |
| CN114159448A (en)* | 2021-12-10 | 2022-03-11 | 深圳先进技术研究院 | Use of a steroid substance in the preparation of an attention-enhancing preparation |
| CN118384103B (en)* | 2024-07-01 | 2024-09-06 | 四川大学 | Microenvironment response type carrier hydrogel and preparation method and application thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4383993A (en)* | 1980-05-30 | 1983-05-17 | University Of Kentucky Research Foundation | Nasal dosage forms containing natural female sex hormones |
| DE3601923A1 (en)* | 1986-01-23 | 1987-07-30 | Behringwerke Ag | NASAL APPLICABLE MEDICINE, METHOD FOR THE PRODUCTION AND USE THEREOF |
| IT1222395B (en)* | 1987-07-30 | 1990-09-05 | Pierrel Spa | PHARMACEUTICAL COMPOSITION FOR INTRANASAL ADMINISTRATION INCLUDING THE HORMONE GHRH, A COLINERGIC AGONIST AND / OR A BILE SALT |
| CA2070823C (en)* | 1989-12-05 | 1999-01-12 | William H. Ii Frey | Neurologic agents for nasal administration to the brain |
| DE4218291A1 (en)* | 1992-06-03 | 1993-12-09 | Mattern Et Partner Pharmazeuti | Dosing spray for pernasal application |
| WO1996000069A1 (en)* | 1994-06-23 | 1996-01-04 | The Procter & Gamble Company | Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration |
| PL331357A1 (en)* | 1996-07-23 | 1999-07-05 | Pherin Pharmaceuticals | Steroids as neurochemical vno stimulators for soothing the symptoms of premenstrual tension and anxiety |
| AU4045097A (en)* | 1996-07-23 | 1998-02-10 | Wilson T. Crandall | Transdermal transport of molecules |
| US5837289A (en)* | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
| JP2002519310A (en)* | 1998-06-29 | 2002-07-02 | ファーマシューティカルズ アプリケーションズ アソシエイツ， エルエルシー | Methods and transdermal compositions for pain relief |
| Publication number | Publication date |
|---|---|
| WO2001041732A1 (en) | 2001-06-14 |
| CA2325106A1 (en) | 2001-06-06 |
| Publication | Publication Date | Title |
|---|---|---|
| AU1261501A (en) | Compositions and methods for intranasal delivery of active agents to the brain | |
| AU4996300A (en) | Method of electroporation-enhanced delivery of active agents | |
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU7389300A (en) | Methods of administration of glycopyrrolate compositions | |
| AU2002243277A1 (en) | Methods and compositions for encapsulating active agents | |
| AU2001236457A1 (en) | Compounds and compositions for delivering active agents | |
| AU5905400A (en) | Methods and compositions for delivery and retention of active agents to lymph nodes | |
| AU4460900A (en) | Carrier patch for the delivery of agents to the skin | |
| AU2093101A (en) | Compositions for efficient release of active ingredients | |
| AU2001284985A1 (en) | Compounds and compositions for delivering active agents | |
| IL148933A0 (en) | Compositions and methods for tumor-targeted delivery of effector molecules | |
| AU2609901A (en) | Antimicrobial compositions and methods of use | |
| AU2003229084A1 (en) | Methods and formulations for the delivery of pharmacologically active agents | |
| IL142807A0 (en) | Controlled delivery of active agents | |
| AU7620200A (en) | Compositions and methods relating to the inhibition of casomorphin and gluteomorphin | |
| AU5326100A (en) | Pharmaceutical compositions and methods for use | |
| AU2001288277A1 (en) | Compounds and compositions for delivering active agents | |
| AU2001271031A1 (en) | Cosmetic compositions for reducing and method of using the same | |
| AU6056500A (en) | Process and composition for temporarily suppressing pain | |
| AU1969800A (en) | Combination of active agents | |
| AU2002316200A1 (en) | Compound and composition for delivering active agents | |
| AU7792900A (en) | Distribution of certifiers | |
| HUP0303178A3 (en) | Methods and compositions for reducing the taste of pharmaceutically active agents | |
| AU3774100A (en) | Heat-activated cleaning compositions with wrinkle-resistance and methods of use | |
| AU5802800A (en) | Form of administration for applying in body orifices |
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |